er such pro forma
financial information in isolation from, or as a substitute for, financial
information prepared in accordance with GAAP.
Pro Forma Reconciliation to GAAP
Consolidated Statements of Operations
In Thousands, Except per Share Amounts
(unaudited)
Twelve Months Ended
December 31, 2007
As Reported(GAAP) Adjustments Pro Forma
Revenue, net:
Product revenue, net:
Core companion animal health $65,910 $- $65,910
Other vaccines, pharmaceuticals
and products 14,897 - 14,897
Total product revenue, net 80,807 - 80,807
Research, development and other 1,528 - 1,528
Total revenue 82,335 - 82,335
Cost of revenue:
Cost of products sold 48,874 - 48,874
Cost of research, development
and other 274 - 274
Total cost of revenue 49,148 - 49,148
Gross profit 33,187 - 33,187
Operating expenses:
Selling and marketing 16,109 - 16,109
Research and development 2,679 - 2,679
General and administrative 8,925 - 8,925
Other (47) - (47)
Total operating expenses 27,666 - 27,666
Income from operations 5,521 - 5,521
Interest and othe
'/>"/>
SOURCE Heska Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 Related medicine news :1.
Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast2.
Heska to Present at Friedland Investment Events Life Sciences Conference3.
Heska to Present at the BioWest 2007 Mature Company Forum4.
Heska to Present at New York Society of Security Analysts Biotech/Specialty Pharma Conference5.
Heska Announces Amended Agreement With AgriLabs6.
Louise McCormick Joins Heskas Board of Directors7.
Webcast Alert: Heska Announces Fourth Quarter and Year-End 2007 Earnings Conference Call Webcast8.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness9.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael10.
UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West11.
HEI, Inc. Announces Sale of RFID Division Assets